
L&T Q1 Results FY26: Q1 PAT Rose 29.85% to ₹3,617.19 Crore; Revenue Surged 15.53% YoY
L&T Q1 Results FY26
Updated: 30 Jul 2025 • 12:06 pm
Posted by:

L&T Q1 Results FY26: Extracts of FY25 & FY26 (Consolidated Figures)
| Particulars | Quarter Ended | |
| 30-06-2025 | 30-06-2024 | |
| Revenue from Operations | ₹63,687.92 | ₹55,119.82 |
| Profit Before Tax (PBT) | ₹9,380.89 | ₹7,966.46 |
| Profit After Tax (PAT) | ₹3,617.19 | ₹2,785.72 |
(Figures in crores)
L&T Q1 Results FY26: Extracts of FY25 & FY26 (Standalone Figures)
| Particulars | Quarter Ended | |
| 30-06-2025 | 30-06-2024 | |
| Revenue from Operations | ₹33,470.73 | ₹30,277.15 |
| Profit Before Tax (PBT) | ₹4,997.05 | ₹4,442.39 |
| Profit After Tax (PAT) | ₹3,485.30 | ₹2,969.09 |
(Figures in crores)
L&T Results FY26 Highlights (Q1 FY26 vs FY25)
- L&T clocked Q1 FY26 consolidated revenue of ₹33,470.73 crores vs ₹30,277.15 crores.
- On the profit front, L&T earned a consolidated PAT of ₹3,485.30 crore in Q1 FY26. During FY25, the company’s PAT stood at ₹2,969.09 crore.
- Consolidated PAT rose for the first quarter of FY26, was 29.85% YoY, and revenue soared 15.53% YoY.
- As per the standalone figures, the quarterly PAT of L&T has increased by 17.55%, and revenue has surged by 10.55% YoY.
L&T Share Price Performance
On the opening bell of 30th July 2025, the shares of L&T opened at ₹3,601.00 per share. However, the initial gains are sustained as of now, and L&T shares are trading at ₹3,645.80 per share, higher than their opening price.
Considering the long-term performance, L&T shares have yielded close to -3.51% returns in the past 1 year, and 5-year returns stand at 299.78%. Over the maximum timeframe, the L&T share provided 19,942.50% returns to investors. However, one must ignore the risk of volatility in the stock market and invest in L&T shares after thorough research.
For regular stock updates, dividend alerts, and expert verdicts, stay informed with Univest!
Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.
Recent Articles
Renol Polychem IPO GMP & Review: Apply or Avoid?
Railway penny stocks in India for 2025 | Railway Penny Stocks List
Cash Ur Drive Marketing IPO GMP & Review: Apply or Avoid?
Piramal Pharma Q1 Results FY26: Q1 Loss Narrows 7.83% to ₹81.70 Crore; Revenue Fails 0.89% YoY
NTPC Green Energy Q1 Results FY26: Q1 PAT Rose 59.07% to ₹220.48 Crore; Revenue Surged 17.59% YoY
Railtel Q1 Results FY26: Q1 PAT Rose 35.81% to ₹66.10 Crore; Revenue Surged 33.27% YoY
Recent Articles
Cantabil Retail India Share Analyst Review: CMP, Performance, Target and 2026 Outlook
4 June 2026

CMR Green Technologies IPO GMP Day 2 on 4 June 2026: Grey Market Premium Rs 61 to Rs 63, Expected Listing Price Rs 253 and Subscription Analysis
4 June 2026

B. L. Kashyap and Sons Share Analyst Review: CMP, Performance, Target and 2026 Outlook
4 June 2026

SMR Jewels IPO Listing Preview on 3 June 2026: GMP at Rs 0, Issue Price Rs 135 and What Investors Should Know
4 June 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Cantabil Retail India Share Analyst Review: CMP, Performance, Target and 2026 Outlook
CMR Green Technologies IPO GMP Day 2 on 4 June 2026: Grey Market Premium Rs 61 to Rs 63, Expected Listing Price Rs 253 and Subscription Analysis
B. L. Kashyap and Sons Share Analyst Review: CMP, Performance, Target and 2026 Outlook
SMR Jewels IPO Listing Preview on 3 June 2026: GMP at Rs 0, Issue Price Rs 135 and What Investors Should Know
Blue Jet Healthcare Share Analyst Review: CMP, Performance, Target and 2026 Outlook
Popular this week
Cantabil Retail India Share Analyst Review: CMP, Performance, Target and 2026 Outlook
CMR Green Technologies IPO GMP Day 2 on 4 June 2026: Grey Market Premium Rs 61 to Rs 63, Expected Listing Price Rs 253 and Subscription Analysis
B. L. Kashyap and Sons Share Analyst Review: CMP, Performance, Target and 2026 Outlook
SMR Jewels IPO Listing Preview on 3 June 2026: GMP at Rs 0, Issue Price Rs 135 and What Investors Should Know
Blue Jet Healthcare Share Analyst Review: CMP, Performance, Target and 2026 Outlook

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas





